Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies.

Hartung-Knemeyer, Verena; Nagarajah, James; Jentzen, Walter; Ruhlmann, Marcus; Freudenberg, Lutz S; Stahl, Alexander R; Bockisch, Andreas; Rosenbaum-Krumme, Sandra J

Hartung-Knemeyer, Verena; Nagarajah, James; Jentzen, Walter; Ruhlmann, Marcus; Freudenberg, Lutz S; Stahl, Alexander R; Bockisch, Andreas; Rosenbaum-Krumme, Sandra J.

Affiliation

Hartung-Knemeyer V; Department of Nuclear Medicine, Medical Faculty, University Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany. verena.hartung@uk-essen.de

Ann Nucl Med ; 26(9): 723-9, 2012 Nov.

Article in En | MEDLINE | ID: mdl-22802008

Subject(s)

Blood Cell Count; Thyroid Neoplasms/blood; Thyroid Neoplasms/radiotherapy; Adult; Aged; Aged, 80 and over; Female; Humans; Iodine Radioisotopes/therapeutic use; Male; Middle Aged; Radiometry; Radionuclide Imaging; Radiotherapy Dosage; Risk; Thyroid Neoplasms/diagnostic imaging; Thyrotropin/blood; Thyrotropin/pharmacology; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Blood Cell Count / Thyroid Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Nucl Med Journal subject: MEDICINA NUCLEAR Year: 2012 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google